When we get something wrong, we fix it on the story and list it here. Newest first.
How corrections work: a dated Correction line is added at the bottom of the story when a fact was wrong, and a dated Update line when we add important context or change our framing. Typos and broken links are fixed without a note. Read our full editorial standards.
Found an error? Use “Report an error” under any story or the contact form, with the story link and, ideally, a source.
Corrections and updates log
- Oct 30, 2026 · Update: Binance Says Hack Hit an Estimated $6.3B and Blames an Engineer’s Laptop. We added Binance’s second update, which says its investigation found “additional points of breach” beyond the laptop, about $3 billion frozen and a phased withdrawal restart, plus Elliptic’s North Korea attribution.
- Oct 29, 2026 · Update: Alphabet Shed About $500 Billion in a Morning. The story was published during trading and cited intraday figures; we added the closing numbers (down about 12.6%, a $482 billion loss by Yahoo Finance’s count, about $3.47 trillion in remaining value).
- Oct 29, 2026 · Correction: The 10 Most Advanced Robots Right Now, Ranked. We said Figure ran “one fixed version” of Helix 2.5 across its home test; Figure’s report says it used one frozen checkpoint per job, each adapted from a single pretrained model. We also explained how the ranking was made and labeled company-reported results.
- Oct 29, 2026 · Update: Show Me the Money: Anthropic Opens Its Books. The headline and introduction added three different kinds of financing into a “nearly $200 billion” total; we removed the total. We also corrected the S-1’s Claude Code comparison (users, not customers) and now cite the filing for the $72.4 billion fair-value charge.
- Oct 29, 2026 · Update: Two AI Labs Say They Killed the Exponential Time Hypothesis. We narrowed our description of the paper’s 1010,000 threshold to the formulas it specifies, and removed our own guess about whether the result will hold up.
- Oct 29, 2026 · Update: FDA Approves Pfizer’s Talzenna Combo. We added the trial registry link, made clear the 52% figure is a relative risk reduction, and attributed a claim about earlier treatment to Pfizer.